Test Price
2,800 AED✅ Home Collection Available
SCN2A Gene (Early Infantile Epileptic Encephalopathy Type 11) Genetic Test in UAE | 2800 AED | 2026 DHA-MOHAP Guidelines
تحليل الجين SCN2A (الصرع الدماغي المبكر النوع 11) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي - دقة تشخيصية 99.9% بموجب معايير ISO 9001:2015
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain, VIP Mobile Phlebotomy (8 AM–11 PM).
- Clinical Guidance: Complimentary telephonic post-test clinical guidance by DHA-licensed neurologist.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
- Compliance: Fully adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL.
Clinical Overview
The SCN2A gene test employs Next Generation Sequencing to detect pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 11 (EIEE11), enabling precise diagnosis and tailored management.
This assay covers all coding exons and splice junctions, with confirmatory Sanger sequencing for identified variants, achieving >99.9% analytical sensitivity and specificity.
| Feature | Our Test (SCN2A NGS) | Closest Alternative (Sequential Single-Gene Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | ~95%, limited to known hot-spots |
| Method | NGS (Next Generation Sequencing) with Sanger validation | Sanger sequencing of selected exons |
| Speed | 3–4 weeks (comprehensive report) | 4–6 weeks (often sequential) |
Physician Insight & Safety Protocol
“As a DHA-licensed neurologist, I emphasize that a positive SCN2A result must be correlated with electroclinical findings; not all variants are pathogenic, and non-neurological phenotypes exist. Our team ensures thorough pre- and post-test counseling to navigate this complexity.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning: Do not discontinue prescribed anti-epileptic medication without consulting your treating physician; abrupt cessation may trigger life-threatening seizures.
Exclusion Criteria & ER Red Flags
- Exclusion: Inability to provide informed consent (or legal guardian consent for minors).
- Exclusion: Acute intercurrent illness that precludes safe venipuncture.
- ER Red Flag: Prolonged seizure (>5 minutes) or repeated seizures without regaining consciousness – seek emergency care immediately.
- ER Red Flag: New-onset focal neurological deficit or altered consciousness.
- ER Red Flag: Respiratory distress or cyanosis during feeding in neonates—urgent evaluation needed.
Patient FAQ & Clinical Guidance
1. What is the SCN2A genetic test used for?
Answer: This test identifies mutations in the SCN2A gene that cause Early Infantile Epileptic Encephalopathy Type 11, enabling precise diagnosis, tailored anti-epileptic therapy, and family counseling. It is recommended for infants and children with early-onset seizures unresponsive to standard treatments. Testing can also clarify prognosis and recurrence risk for future pregnancies.
١. ما هو فحص الجين SCN2A المستخدم؟
يحدد هذا الفحص الطفرات في جين SCN2A المسببة للصرع الدماغي المبكر النوع 11، مما يسمح بتشخيص دقيق وعلاج مضاد للصرع مخصص واستشارة عائلية.
2. How do I prepare for the and what is the sample required?
Answer: A genetic counselling session and a detailed clinical history, including a family pedigree, are mandatory before sample collection. The sample can be blood (2-3 mL in EDTA tube), extracted DNA, or a few drops on an FTA card. Fasting is not required. Our home collection team will handle the cold-chain transport.
٢. كيف أستعد للفحص وما هي العينة المطلوبة؟
جلسة استشارة وراثية وتاريخ سريري مفصل، بما في ذلك شجرة العائلة، إلزامية قبل جمع العينة. يمكن أخذ العينة من الدم أو الحمض النووي المستخلص أو بضع قطرات على بطاقة FTA.
3. When will I receive my results and how are they interpreted?
Answer: Results are available within 3 to 4 weeks and include a detailed report classifying variants as pathogenic, likely pathogenic, or uncertain significance. Our DHA-licensed neurologist will explain the findings, discuss implications for treatment, and advise on the need for parental testing. Any actionable result is communicated immediately via secure WhatsApp.
٣. متى سأتلقى النتائج وكيف يتم تفسيرها؟
النتائج متاحة في غضون 3 إلى 4 أسابيع وتشمل تقريرًا مفصلًا يصنف الطفرات. سيقوم طبيب الأعصاب المرخص من هيئة الصحة بدبي بشرح النتائج ومناقشة خيارات العلاج.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians